Results 111 to 120 of about 49,575 (291)
Band‐Selective IR PRESS for Brain Tumor Spectroscopy Allows Robust Detection of Lactate
NMR in Biomedicine, Volume 39, Issue 3, March 2026.Lactate quantification by MRS is hindered by lipid signal overlap at 1.3 ppm, frequently forcing the use of long echo times that suppress other metabolites. We developed SPIR‐PRESS, a selective inversion recovery technique that suppresses lipids while preserving metabolite sensitivity.
Shun Kishimoto +12 more
wiley +1 more source
Non‐Invasive, High‐Resolution (1H2O) Metabolic Activity Diffusion Imaging [MADI] of Rat Glioma
NMR in Biomedicine, Volume 39, Issue 3, March 2026.We employed Metabolic Activity Diffusion Imaging [MADI] and 18FDG‐PET in rats with syngeneic RG2 glioblastoma brain tumors. MADI quantifies kio (the cellular H2O efflux rate constant), cell volume (V), and cell density (ρ), without the use of contrast agents. The kioV product quantifies the rate of water efflux per cell.
Joshua W. Schlegel +9 more
wiley +1 more source
Evaluating consistency of radiomic features derived from CT images: A cross‐center phantom study
Journal of Applied Clinical Medical Physics, Volume 27, Issue 2, February 2026.Abstract Purpose To investigate the consistency of radiomic features extracted from computed tomography (CT) scans across CT radiotherapy simulators geographically spread across a Canadian province using a simplified lung radiomic phantom, and to determine whether it is appropriate to combine multicenter imaging data into a single dataset.
Lorna Tu +5 more
wiley +1 more source
Outcomes of Liver Transplantation Following Stereotactic Body Radiotherapy for Hepatocellular Carcinomas [PDF]
, 2019 Yijie Zhao +3 more
openalex +1 more source
Potential Targets and Biomarkers of Radionuclide Therapy in Breast Cancer
Cancer Innovation, Volume 5, Issue 1, February 2026.Potential biomarkers for the development of targeted radionuclide therapy that can be employed in the treatment of breast cancer have been summarised in the review. They include receptor markers of ER, PR and HER2, as well as other markers of Trop2, PD‐1, EGFR, GRPR and PSMA.
Yujing Tan +3 more
wiley +1 more source
Cancer Medicine, Volume 15, Issue 2, February 2026.ABSTRACT Aim Integration of locoregional treatments (LRTs) with atezolizumab plus bevacizumab (atezo/bev) has improved treatment outcomes, enabling an increasing number of patients with unresectable hepatocellular carcinoma (HCC) to achieve a complete response (CR). A comprehensive analysis of recurrence following CR may provide insights into prognosis.
Tasuku Nakabori +11 more
wiley +1 more source
Lateral Deviation of the Tongue in an Otherwise Asymptomatic Patient
Oral Diseases, EarlyView.
Giulia Ghidini +4 more
wiley +1 more source
Cancer Reports, Volume 9, Issue 2, February 2026.ABSTRACT Purpose Spinal metastases may cause pain, neurological compromise, paraplegia, and limb movement disorders; their management requires a comprehensive approach. Alongside systemic anti‐tumor therapies, focal interventions such as radiotherapy, bone‐modifying agents, and surgery are crucial for slowing disease progression and managing pain in ...
Lu Sun +6 more
wiley +1 more source